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Objectives.The aim of this study was to determine the effectiveness of preoperative administration of single-dose of paracetamol-
codeine, in the relieving of acute postoperative pain after the surgical removal of an impacted mandibular third molar. Materials
andMethods.The study cohort consisted of 32Caucasian outpatients, giving a total of 64 bilateral symmetrical impactedmandibles.
Patients were randomized in two experimental groups to receive a preoperative oral dose of paracetamol-codeine (analgesic group)
or a placebo (placebo group) at the first and second surgeries. Study participants were asked to record pain intensity scores during
the operation and the next 2days, the time of thefirst request for rescue analgesic, and the total number of postoperative-supplement
paracetamol-codeine tablets. Results.The pain intensity score on the first day was significantly lower in the analgesic group than in
the placebo group (푝 < 0.001).The time to using rescue therapy was significantly longer in the analgesic group than in the placebo
group (푝 = 0.004). The number of paracetamol-codeine tablets used postoperatively did not differ between the analgesic and
placebo groups (푝 = 0.104). Conclusions. Preoperative paracetamol-codeine is effective in providing immediate postoperative pain
control after third molar surgery and in delaying the initial onset of pain.This trial is registered with ClinicalTrials.gov Identifier
(Registration Number): NCT03049878.
1. Introduction
The removal of impacted mandibular third molars is nowa-
days one of the most frequent oral surgical procedures.
Nevertheless, postsurgical complications such as acute post-
operative pain, swelling, bruising, and limited mouth open-
ing occur frequently, and these have an immediate negative
impact on the working and social lives of patients [1, 2].
The postoperative pain is undoubtedly the most unpleasant
symptom for the patient and, despite receiving analgesic
therapy, may persist even 1 week after the surgery, leading
to increased morbidity and negatively influencing the well-
being and quality of life [3–5].
Various analgesic combinations have been proposed for
minimizing this complication. Combining different phar-
macologic classes of analgesic drugs that have different
mechanisms of action and side-effect profiles, resulting in
additive or synergic effects, may improve the efficacy of pain
therapy [6]. In addition, the use of the individual drugs at
lower doses in such combinations is associated with a lower
incidence of adverse effects [7, 8].
Furthermore, a single tablet containing two different
analgesics at fixed doses seems to provide better relief of
acute postoperative pain than the individual administration
of the same drugs as separate tablets [9]. There are many
reports in the literature of the effectiveness of combined
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paracetamol–codeine preparations for postoperative pain
after the removal of wisdom teeth [8].
Paracetamol (also called acetaminophen) is a commonly
prescribed analgesic used extensively in the management of
acute pain, although its exactmechanism of action is not fully
understood.
Paracetamol is absorbed well upon oral administration,
reaching peak concentrations in 30–60min, and its half-
life is 2-3 hours. At a dosage of 4 g/day at 6-hour intervals,
paracetamol is well tolerated in adults without compromising
safety, although overdose has been linked to adverse events
such as severe hepatotoxicity [7, 10].
Codeine (3-methylmorphine) is a mild opioid that is
absorbed well upon oral administration with a weak anal-
gesic effect [11].The combination with paracetamol provides
greater pain relief and is useful in controlling mild-to-
moderate pain. The elimination half-life of codeine is 2.9
hours. Codeine at the adult normal dose (30–60mg every
4 hours orally to a maximum of 240mg daily) causes no
euphoria or respiratory depression and is rarely addictive
[7, 12].
The primary outcome of this randomized, split-mouth,
placebo-controlled, double-blind clinical trial was the effi-
cacy of preoperative administration of single-dose paracet-
amol-codeine in reducing pain intensity after the surgical
removal of an impacted mandibular third molar under local
anaesthesia. Additional analgesic efficacy outcomes included
the number of patients using rescue therapy, time to the
first use of rescue analgesia, total number of postoperative-
supplement paracetamol-codeine tablets and the incidence
of adverse effects occurring in each study group during the
study period.
2. Materials and Methods
2.1. Study Design and Sample. This randomized, split-mouth,
placebo-controlled, double-blind clinical trial was carried out
at the Oral Surgery Unit, Policlinico Umberto I at “Sapienza”
University of Rome, Italy, in accordance with standards of
GoodClinical Practices for analgesic drugs andwas approved
by the local ethical committee (reference 2704/21.02.2013)
in compliance with the 1964 Declaration of Helsinki on
medical protocol and ethics and its later amendments or
comparable ethical standards. Before giving their consents,
all participants were informed of the possible risks associated
with impacted mandibular third molar extraction and the
aim of the experimental protocol.
Patient recruitment was conducted between April 2013
and September 2015 according to the CONSORT statement.
The sample unit used in the present studywas the surgical site.
The study cohort consisted of Caucasian outpatients of both
genders, aged between 20 and 29 years, selected to undergo
elective surgical removal of bilateral symmetrical impacted
mandibular third molars under local anaesthesia.
Subjects were enrolled using the following criteria:
absence of systemic pathologies (ASA class I); nonsmoker;
not pregnant or lactating; good oral hygiene; no drug con-
sumption for 10 days before the operation; bilateral impacted
mandibular third molars with comparable position, depth,
and inclination; presence of the first and second molars;
absence of painful symptoms and associated inflammatory
or osteolytic pathologies in a radiographic examination;
extraction difficulty index of >7 according to Pederson’s scale
[13] and a degree of IV (complex procedures) on a modified
version of Parant’s scale [14, 15].
Patients were randomized into two experimental groups:
(1) preoperative oral dose of paracetamol-codeine (500-
mg paracetamol + 30-mg codeine) (analgesic group) and
(2) placebo (starch) (placebo group). One month after the
first surgery, at complete wound healing, the analgesic and
placebo groups underwent the second surgery for thirdmolar
extraction on the opposite side, but with the preoperative
treatment inverted: those originally in the analgesic group
received placebo and those originally in the placebo group
received paracetamol-codeine. All of the operations were
performed by the same experienced surgeon in order to
minimize variations in the surgical technique.
2.2. Randomization. Presurgical analgesic treatment (parac-
etamol-codeine versus placebo) was assigned using a list
of random numbers generated using CLINSTAT software
(Martin Bland, York, UK) before the start of the study.
2.3. Blinding. The patients, surgeon, and statistician were all
blinded to the type of presurgical treatment (double-blind
procedure). The only nonblinded person was an external
study collaborator involved in the verification of doses, who
also had to record the code indicating to which group each
patient had been assigned until the conclusion of the study.
2.4. Surgical Technique. Surgery was performed under local
anaesthesia. The nerve block was achieved with 3% mepi-
vacaine and the soft-tissue infiltration with 2% mepivacaine
and 1 : 100,000 adrenaline (Carbocaine, AstraZeneca, Italy). A
mucoperiosteal flap was raised by making an incision distal
to the lower second molar along the length of the anterior
border of the ascending ramus of the mandible. Ostectomy
and tooth sectioning were then performed. After completely
extracting the tooth, the socket was revised and the flap was
sutured with interrupted synthetic nonabsorbable sutures
(4/0 Ethilon!, Ethicon Ltd, UK). The surgery duration was
measured from the start of the surgical procedure until
completing the last suture.The sutures were removed 1 week
later.
2.5. Study Medication. Professional oral hygiene was applied
7–10 days prior to surgery. One hour before the operation, all
patients received antibiotic prophylaxis with 2-g amoxicillin
+ clavulanic acid (Augmentin, GlaxoSmithKline, Italy) to
prevent postsurgical infection.
Fifteen minutes before surgery, one tablet containing
either 500-mg paracetamol + 30-mg codeine (Coefferalgan,
Farma 1000, Italy) or starch (placebo) was administered
orally; the two types of tablets had an identical appearance.
Immediately before applying local anaesthesia, all partici-
pants were instructed to execute three mouth rinses with
an antiseptic at 0.20mg/ml (0.2% chlorhexidine, Corsodyl,
GlaxoSmithKline, Italy).
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Table 1: Comparison of objective measurement data between the placebo and analgesic groups.
Analgesic group Placebo group 푝
Surgery duration (min) 30.47 ± 12.03 34.76 ± 12.21 0.202
Pain intensity scores on the first day 3.18 ± 2.18 4.65 ± 2.73 0.001∗
Pain intensity scores on the second day 2.22 ± 1.88 2.53 ± 2.12 0.134
Pain intensity scores on the third day 1.81 ± 1.77 2.01 ± 2.31 0.468
Time to first using analgesic intake (min) 414.33 ± 131.26 288.67 ± 116.63 0.004∗
Total rescue therapy intake (no. of tablets) 1.24 ± 1.82 1.47 ± 1.66 0.104
No. of patients who took no rescue analgesic 8 6 0.364
Data expressed as the mean ± standard deviation or number of patients.
Asterisks indicate significant differences.
Postsurgical instructions were given to each patient con-
cerning food consumption as well as hygiene at the surgical
site (0.2% chlorexidine spray, Corsodyl, GlaxoSmithKline,
Italy). During this period, both groups of patients (analgesic
and placebo) were allowed to take the same paracetamol-
codeine tablets given preoperatively at 6-hour intervals
depending on their pain symptoms (up to a maximum of 4-g
paracetamol and 240-mg codeine per 24 hours). Any adverse
events (nausea, vomiting, headaches, or dizziness) occurring
between the start of the trial and 1 week later at the time of
suture removal were recorded.
2.6. Postoperative Pain and Rescue-Therapy Evaluation. The
primary outcome of the study was the postoperative pain.
Before surgery, patients were instructed to complete the
Numerical Rating Scale-11 (NRS-11), which consisted of an
interval scale ranging from 0 (“no pain”) to 10 (“maximum
pain”) [16, 17]. All study participants were asked to record
the pain intensity score at 1:00, 6:00, and 11:00 pm during the
operative day and at 8:00 am, 1:00, 6:00, and 11:00 pm during
the next two days.
Additional outcomes included the number of patients
using rescue therapy, the time elapsed from the end of
surgery until the first intake of analgesic medication, and
the total number of paracetamol-codeine tablets with the
same formulation taken by the patient in relation to the pain
symptoms.
The effects on acute postoperative pain and rescue ther-
apy were assessed only until the third day after surgery, since
the onset of pain usually begins immediately after the local
anaesthetic wears off, with a peak intensity after 6–8 hours
and possibly persisting for a few days only [15, 18].
2.7. Statistical Analysis. The required sample size was cal-
culated using statistics software (GPower 3.1.9.2, Heinrich-
Heine-Universita¨t, Du¨sseldorf, Germany) [19]. A power anal-
ysis using the Wilcoxon matched-pairs signed-rank test
with an 훼 level of 0.05 showed that 32 subjects would be
adequate to obtain 80% power in detecting a statistical
difference between 2 groups in scores on the NRS-11 for
post-operative pain, assuming a loss to follow-up of 20%.
The power calculation was based on the pain scores in
a previous pilot study involving five patients (2.33 ± 2.00
[mean ± SD] for paracetamol-codeine and 2.92 ± 2.59 for
placebo).
A databasewas created using Excel (Microsoft, Redmond,
WA, USA), with appropriate checks used to identify errors.
Descriptive statistics including mean and SD values were
used. The Kolmogorov-Smirnov test was used to determine
whether or not the data conformed to a normal distribution.
The Wilcoxon signed-rank test was used to assess differences
in pain intensity between the two groups. The paired t-test
was used to compare between the two groups regarding the
time of surgery, the time to the first use of rescue medication,
and the amount of rescue analgesic taken. Fischer’s exact test
was used to assess the difference in the number of patients
who required rescue therapy in the two groups. The Mann-
Whitney test was used to evaluate the difference in the pain
intensity between patients who took the analgesic drug in
the first and second surgeries and between patients who
took the placebo in the first and second surgeries. Data
were evaluated using standard statistical analysis software
(Statistical Package for the Social Sciences, version 20.0, IBM
Corporation, Armonk, NY, USA). In each test the cut-off for
statistical significance was 푝 ≤ 0.05.
3. Results
In total, 32 patients were screened for study eligibility,
comprising 17 females and 15 males with ages ranging from
20 to 29 years (22.65 ± 2.74 years), providing 64 surgical sites.
There were no dropouts.
The duration of surgery did not differ between the
analgesic (30.47 ± 12.03) and control (34.76 ± 12.21) groups(푝 = 0.202). No adverse events such as nausea, vomiting
headaches, or dizziness were detected. The data are summa-
rized in Table 1.
3.1. Pain Intensity Score. The pain intensity score on the
first day differed significantly between patients receiving the
paracetamol-codeine combination (3.18 ± 2.18) and those
receiving placebo (4.65 ± 2.73, 푝 < 0.001). There was no
difference on the second (푝 = 0.134) and third (푝 = 0.468)
days after surgery.The data are illustrated in Figure 1.
The pain intensity score in the placebo group was sig-
nificantly higher in the second surgery (5.48 ± 2.52) than
in the first surgery (3.48 ± 2.62, 푝 = 0.011). In contrast,
the pain intensity score in the analgesic group did not differ
significantly between the second (2.09 ± 2.02) and first (3.05± 1.75) surgeries (푝 = 0.419) (Table 2).
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Table 2: Comparison of pain scores (NRS-11) between patients who received the analgesic drug in the first surgery and the second surgery
and between patients who received the placebo in the first surgery and the second surgery.
First surgery Second surgery 푝
Pain intensity scores in the analgesic group 3.05 ± 1.75 2.09 ± 2.02 0.419
Pain intensity scores in the placebo group 3.48 ± 2.62 5.48 ± 2.52 0.011∗
Data expressed as the mean ± standard deviation.
Asterisk indicates a significant difference.
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Figure 1: Pain intensity score (NRS-11) in the placebo and analgesic
groups recorded at specific time intervals on the three days after
surgery. Data are expressed as the mean and SD values. Significant
difference in the NRS-11 score between the two groups was found
only in the first day after surgery (푝 < 0.001).
The pain intensity was much higher in patients who
received the preoperative analgesic drug in the first surgery
and the placebo in the second surgery than in patients
who received placebo in the first surgery and the preventive
analgesic drug in the second surgery (Figure 2).
3.2. Rescue Therapy. Six of the 32 patients did not request
rescue therapy for either the first or second surgeries, and
2 required rescue therapy only after treatment with placebo.
The difference between the two groups was not statistically
significant (푝 = 0.364).
The mean time to first using rescue therapy was sig-
nificantly longer in the analgesic group (414.33 ± 131.26
minutes) than in the placebo group (288.67 ± 116.63minutes,푝 = 0.004). The number of postoperative-supplement
paracetamol-codeine tablets used did not differ between the
analgesic (1.24 ± 1.82) and control (1.47 ± 1.66) groups (푝 =0.104).
4. Discussion
This study was designed to assess the effect of preopera-
tive administration of single-dose paracetamol-codeine on
postoperative pain after the surgical removal of an impacted
mandibular third molar under local anaesthesia.
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Figure 2: Box-and-whisker plots related to the pain scores (NRS-
11) in patients which received the placebo or analgesic drug, respec-
tively, in the first or second surgery. The dark line in the middle of
the boxes is the median. The box represents the interquartile (IQ)
range which contains the middle 50% of the records. The whiskers
are lines that extend from the upper and lower edge of the box to the
highest and lowest values which are no greater than 1.5 times the IQ
range.The circles are outliers.These are defined as values that do not
fall in the whiskers.The asterisks or stars are extreme outliers.These
represent cases that have values more than three times the height of
the boxes.
Third molar surgery is considered a validated and widely
used pain model for the clinical evaluation of analgesic
efficacy, because the removal of bone is associated with acute
moderate-to-severe postoperative pain [17].
Furthermore, this procedure has proven selectivity, with
the ability to distinguish active from inactive (placebo)
medications, and it allows randomized clinical trials since it
is often performed bilaterally [17].
The choice of applying tablets containing 500-mg parac-
etamol + 30-mg codeine (Coefferalgan, Farma 1000) was
based on their previously reported effectiveness in relieving
postoperative pain after impacted mandibular third molar
surgery [8].The preoperative administration of paracetamol-
codeine so that its level peaks at the end of the action of
the local anaesthesia seems to provide an optimal analgesic
effect [20] and effectiveness in preventing the production
of prostaglandin, whose concentration in the area of injury
becomes significant about 1 hour after surgery [8, 18, 21].
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In addition, a lower dose of codeine in combination with
paracetamol produces an additive analgesic effect without
increasing the incidence of side effects, with an excellent
safety profile [22, 23].
To the best of the authors’ knowledge, this is the first study
to assess the effect on postoperative pain of a single dose of
500-mg paracetamol + 30-mg codeine administered preop-
eratively in the surgical removal of an impacted mandibular
third molar under local anaesthesia. A few studies have
evaluated the efficacy of 30-mg codeine in combination with
paracetamol, but with doses varying from 300 to 650mg and
with most of them focusing on postoperative administration
or as an intervention during general anaesthesia [8, 24].
Our data indicated that the preoperative administration
of paracetamol-codeine was effective in immediate postoper-
ative pain control, but not in the second and third day after
surgery, and in lengthening the time before requiring post-
operative analgesia.The not statistically significant difference
between the less amount of codeine paracetamol tablets taken
in the analgesic group compared to the placebo group may
be due to the relatively small number of participants The
efficacy of this analgesic premedication was also confirmed
by the different trend in the pain intensity scores for the
first and second extractions between patients pretreated with
paracetamol-codeine as compared to placebo. The patients
who received the preoperative analgesic drug in the first
surgery experienced much stronger pain in the second
surgery performed under placebo compared to the patients
who received the placebo and analgesic drug in the opposite
order. This finding could be due to the experience at the
second extraction being influenced by the experience during
the first. That is, patients who experience the preventive
administration of paracetamol-codeine at the first surgery
would expect a similar experience in the second, and so
their perception of pain is amplified. In contrast, patients
pretreated with placebo at the first surgery experience less
pain than expected at the second surgery due to the preven-
tive effect of the preoperative administration of paracetamol-
codeine.
The lack of adverse events in the present study should be
interpreted with caution due to the relatively small number of
participants. However, adverse events are rare and typically
occur when a higher dose of paracetamol has been taken for
long periods of time or when the intake of codeine exceeds
90mg daily [8].
Our results are consistent with the findings of similar
studies comparing single doses of 30-mg codeine plus 300-
mg paracetamol against placebo, in which this combination
was demonstrated to be effective in immediate postoperative
pain control and in reducing the time before requiring
postoperative analgesia [20, 23, 25].
5. Conclusion
The preoperative administration of paracetamol-codeine sig-
nificantly reduced the intensity of postoperative pain and
increased the time to the first request of rescue therapy com-
pared to placebo.These observations indicate that enhancing
the control of postoperative pain requires the analgesic
therapy to be applied perioperatively, starting before the
surgery, extending into the early postsurgical period and con-
tinuing up to 12–24 hours postoperatively. Delaying analgesic
administration until the patient reports mild-to-severe pain
results in unnecessary discomfort andmay reduce the efficacy
of the treatment.
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